Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

International Collaboration of Trialists.; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group).; European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group.; Australian Bladder Cancer Study Group.; National Cancer Institute of Canada Clinical Trials Group.; Finnbladder.; Norwegian Bladder Cancer Study Group.; Club Urologico Espanol de Tratamiento Oncologico Group., Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK.

J Clin Oncol. 2011 Jun 1;29(16):2171-7. doi: 10.1200/JCO.2010.32.3139.

2.

What are the minimal standards of radiotherapy planning and dosimetry for "hypofractionated" radiotherapy in breast cancer?

MacLeod N, McIntyre A, Canney PA.

Breast. 2010 Jun;19(3):172-5. doi: 10.1016/j.breast.2010.03.007. Review.

PMID:
20511066
3.

Does HER-2 over-expressing breast cancer have a predilection to metastasize to the brain?

Paterson C, Mcintyre A, Canney PA.

Clin Oncol (R Coll Radiol). 2009 Oct;21(8):635-6. doi: 10.1016/j.clon.2009.04.003. No abstract available.

PMID:
19447586
4.

Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring.

Jones AL, Barlow M, Barrett-Lee PJ, Canney PA, Gilmour IM, Robb SD, Plummer CJ, Wardley AM, Verrill MW.

Br J Cancer. 2009 Mar 10;100(5):684-92. doi: 10.1038/sj.bjc.6604909.

5.

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.

Falandry C, Canney PA, Freyer G, Dirix LY.

Ann Oncol. 2009 Apr;20(4):615-20. doi: 10.1093/annonc/mdn693. Review.

PMID:
19254941
6.

Postmastectomy radiotherapy: will the selective use of postmastectomy radiotherapy study end the debate?

Russell NS, Kunkler IH, van Tienhoven G, Canney PA, Thomas J, Bartlett J, van de Vijver MJ, Belkacemi Y, Yarnold JR, Barrett-Lee PJ.

J Clin Oncol. 2009 Feb 20;27(6):996-7; author reply 997-8. doi: 10.1200/JCO.2008.18.7062. No abstract available.

PMID:
19164209
7.

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.

Awada A, Albanell J, Canney PA, Dirix LY, Gil T, Cardoso F, Gascon P, Piccart MJ, Baselga J.

Br J Cancer. 2008 May 6;98(9):1500-7. doi: 10.1038/sj.bjc.6604347.

9.

Acute supraclavicular skin toxicity in patients undergoing radiotherapy for breast cancer: an evaluation of the 'T'-grip method of patient positioning.

Tho LM, McIntyre A, Rosst A, Gallagher C, Yap C, Ritchie DM, Canney PA.

Clin Oncol (R Coll Radiol). 2006 Mar;18(2):133-8.

PMID:
16523814
10.

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer.

Al Murri AM, Bartlett JM, Canney PA, Doughty JC, Wilson C, McMillan DC.

Br J Cancer. 2006 Jan 30;94(2):227-30.

11.
12.
13.

Variation in the probability of cardiac complications with radiation technique in early breast cancer.

Canney PA, Sanderson R, Deehan C, Wheldon T.

Br J Radiol. 2001 Mar;74(879):262-5.

PMID:
11338104
14.
15.

Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation.

Mackean MJ, Cassidy J, Jodrell DI, Paul J, Reed NS, Canney PA, Yosef H, Habeshaw T, Robertson AG, McInnes A, Twelves CJ.

Br J Cancer. 1998 May;77(9):1480-6.

16.

Biphasic cellular repair and implications for multiple field radiotherapy treatments.

Canney PA, Millar WT.

Br J Radiol. 1997 Aug;70(836):817-22.

PMID:
9486046
17.
18.

Carboplatin, 5-fluorouracil and folinic acid: a 48-hour chemotherapy regimen in advanced and recurrent squamous carcinoma of the head and neck.

Hatton MQ, Junor EJ, Paul J, Canney PA, Yosef H, Robertson AG, McGurk FM, Symonds RP.

Clin Oncol (R Coll Radiol). 1996;8(6):380-3.

PMID:
8973855
19.

Repair kinetics in pig epidermis: an analysis based on two separate rates of repair.

Millar WT, Van Den Aardweg GJ, Hopewell JW, Canney PA.

Int J Radiat Biol. 1996 Jan;69(1):123-40.

PMID:
8601751
20.

Phase I study of accelerated FEC with granulocyte colony-stimulating factor (Lenograstim) support.

Bissett D, Jodrell D, Harnett AN, Habeshaw T, Kaye SB, Evans D, Williams M, Canney PA.

Br J Cancer. 1995 Jun;71(6):1279-82.

Supplemental Content

Loading ...
Support Center